Transplant Infections

Dr. Per Ljungman is a professor of hematology and the head researcher of the Per Ljungman Group within the Karolinkska Institutet of Sweden, where he studies antiviral agents and vaccines as well as immune responses to viral infections in the immunocompromised host. He is a visiting professor at the University of Florida and practices medicine at the Karolinska University Hospital. He completed his PhD in virology and his MD in medical studies at the Karolinska Institutet before researching infectious diseases at the University of Washington, Seattle, where he remained for over a decade. He returned to the Karolinska Institutet in 1996 as an Associate Professor and later served as the Head of the Department of Hematology for four years. He has collaborated on over 300 original papers and has published four editions of Transplant Infections, which remains the only comprehensive book of its kind.Dr. David R. Snydman is the Chief of the Division of Geographic Medicine andInfectious Diseases at Tufts University School of Medicine, where he focuses on infectious diseases, cytomegaloviruses, and transplant infectious diseases. He earned his MD from the University of Pennsylvania in 1972 and immediately received his first of twenty prestigious honors and awards. He also trained with the Centers for Disease Control and the Tufts Medical Center and has contributed to over 200 publications.Dr. Michael Boeckh is a professor of medicine at the University of Washington. He is also the Head of the Infectious Disease Sciences Program at the Fred Hutchinson Cancer Research Center and an attending physician at the Seattle Cancer Care Alliance. Dr. Boeckh's primary focuses are infectious diseases in the immunocompromised host, respiratory viruses, and transplantation infections. He completed both a PhD and MD from Freie Universitt Berlin before accepting his Infectious Disease Fellowship at the University of Washington School of Medicine in 1992. Over thecourse of his career, he has collaborated on a multitude of publication on the most cutting-edge techniques in infection detection, treatment, and prevention.

Introduction to Hematopoietic Stem Cell Transplantation.- Introduction to Solid Organ Transplantation.- Immunosuppressive Agents.- Common drug Interactions encountered in treating transplant-related infections.- Diagnostic methods; general principles.- Risks and Epidemiology of Infections after Hematopoietic Stem Cell Transplantation.- Risks and Epidemiology of Infections after Solid organ transplantation.- Donor derived infections. Incidence, prevention, and management.- Transplant infections in developing countries.- Risks and Epidemiology after Heart Transplantation.- Risks after Lung or heart-lung Transplantation.- Infections in Kidney Transplant recipients.- Risks and epidemiology of infections after pancreas or kidney-pancreas transplantation.- Risks and epidemiology of infections liver transplantation.- Risks and epidemiology of infections after intestinal transplantation.- Pneumonia after Hematopoietic Stem Cell or Solid Organ Transplantation.- Central Nervous System Infectionsafter Hematopoietic Stem Cell or Solid Organ Transplantation.- Gastrointestinal infections after solid organ or hematopoietic Stem Cell Transplantation.- Gram-Positive Bacterial Infections after Hematopoietic Stem Cell or Solid Organ Transplantation.- Gram-Negative Bacterial Infections after Hematopoietic Stem Cell or Solid Organ Transplantation.- Typical and Atypical Mycobacterium Infections after Hematopoietic Stem Cell or Solid Organ Transplantation.- Other Bacterial Infections after Hematopoietic Stem Cell or Solid Organ Transplantation.- Cytomegalovirus Infection after Stem Cell Transplantation.- Cytomegalovirus Infection after Solid Organ Transplantation.- Epstein-Barr Virus Infection and Lymphoproliferative Disorders after Transplantation.- Herpes Simplex and Varicella-Zoster Virus Infection after Hematopoietic Stem Cell or Solid Organ Transplantation.- .- Human Herpesvirus-6, 7, and 8 Infections after Solid Organ Transplantation.- Human Herpesvirus-6, 7, and 8 Infections afterHematopoietic Stem Cell Transplantation.- Influenza and Parainfluenza Hematopoietic Stem Cell or Solid Organ Transplantation.- Respiratory Syncytial virus and Metapneumovirus after Hematopoietic Stem Cell or Solid Organ Transplantation.- Other community acquired respiratory virus infections after transplantation.- Adenovirus infections after Hematopoietic Stem Cell Transplantation.- Adenovirus infection in solid organ transplantation.- Polyoma and papillomavirus infections after Transplantation.- Hepatitis virus infections after Solid Organ Transplantation.- Hepatitis B and C after Stem Cell Transplantation.- Yeast Infections after Hematopoietic Stem Cell Transplantation.- Yeast Infections after Solid Organ Transplantation.- Mold Infections after Hematopoietic Stem Cell Transplantation.- Aspergillus and other mold Infections after Solid Organ Transplantation.- Other fungal infections after Hematopoietic Stem Cell or Solid Organ Transplantation.- Toxoplasmosis after Hematopoietic StemCell Transplantation.- Toxoplasmosis after Solid Organ Transplantation.- Parasites after Hematopoietic Stem Cell or Solid Organ Transplantation.- Infection Control Issues after Hematopoietic Stem Cell Transplantation.- Infection Control Issues after Solid Organ Transplantation.- Vaccination of Transplant Recipients.- Growth Factors and Other Immunomodulators.- Adoptive Immunotherapy with Herpesvirus-Specific T Cells.- Emerging and rare viral infections in transplantation.- Travel Medicine, Vaccines, and Transplant Tourism.- Microbiome in Transplantation.- Special consideration for long term survivors.